Recombinant human growth hormone for somatotropic research.
Recombinant human growth hormone (rhGH, somatropin) is a 191-amino-acid protein used in research of the somatotropic axis and body-composition modeling.
Binds the GH receptor, activating JAK2/STAT5 signaling and inducing hepatic IGF-1 production.
Peptide engages target receptor with high affinity.
Downstream intracellular pathways activate.
Gene expression and protein synthesis shift.
Measurable change in the studied biomarker.
Reviewed GH effects on glucose, lipid and protein metabolism.
Documented lipolysis, insulin antagonism, and protein-anabolic effects.
Systematic review of GH in healthy older adults.
Small reductions in fat mass and increases in lean mass; elevated adverse events.
Foundational RCT of GH on body composition in older men.
Increased lean mass and decreased adipose with GH vs. control.
Lyophilized 2–8°C. Reconstituted: 2–8°C, use within 14 days.
Strictly for in-vitro laboratory and research investigations.
Not approved for diagnostic, therapeutic, or veterinary application.
Handling restricted to licensed researchers and laboratory staff.
Warning — HGH is supplied solely for legitimate laboratory research. Any administration to humans or animals is strictly prohibited and may violate federal, state, or local law. By purchasing, the researcher accepts full responsibility for safe handling, storage, and lawful use.
